FDA Found to Be Lax on Oversight During Trials

A new study has found that the FDA does very little when it comes to monitoring doctors who may have financial conflicts with companies whose drugs and medical devices they are supposed to be testing. Perhaps the most damning finding was the revelation that agency officials didn’t believe it was “worth the effort” to try to protect patients from such conflicts of interest.
This latest study is just the latest in a myriad of bad press, resignations, and reports of mismanagement at the federal agency. This is especially bad since the courts have virtually left consumer safety in the hands of the FDA regarding the safety of medical devices.
According to the NY Times article, “Fewer than 1 percent of the doctors who helped oversee clinical trials registered with the agency and who filed the required financial disclosure forms reported that they had a significant conflict of interest. By contrast, studies have found that one-fifth to one-third of all doctors have such conflicts.”